Retrieval Practice and Schizophrenia
This study has public registry information. It focuses on schizophrenia and currently lists study information in France.
In France
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has public registry information. It focuses on schizophrenia and currently lists study information in France.
In FranceThis study has public registry information. It focuses on depression and currently lists study information in France.
In FranceThis study is completed in France. It focuses on ADHD.
In FranceThis study is completed. It focuses on bipolarity and currently lists study information in France.
In FranceThis study is completed. It focuses on anxiety and currently lists study information in France.
In FranceThis study has public registry information. It focuses on bipolarity and currently lists study information in Bulgaria, Canada, Czech Republic, France, Poland, Romania, Spain, Turkey, and the United States.
In FranceThis study is completed. It focuses on bipolarity and currently lists study information in Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, the United States, and Venezuela.
In FranceThis study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.
In FranceThis study is completed in France. It focuses on depression.
In FranceThis study is completed. It focuses on depression and currently lists study information in France.
In FranceThis study is active but not recruiting. It focuses on bipolarity and currently lists study information in France.
In FranceThis study is completed. It focuses on ADHD and currently lists study information in France.
In France